Medical device and informatics company with disruptive technology focused on female reproductive health including help to get pregnant, birth control and screening for cervical cancer. Numerous other important applications. Seeks founder investor - attractive terms incl. repayment of invested cash via profit sharing. Our first consumer product will be manufactured within 7 months after funding, whereas a predicate prototype has previously received the FDA 510k certification with proof of concept clinical studies. The first tranche of financing will fund repackaging of the clinical prototype of the Ovulona™ biosensor into the marketable product and a multi-center clinical study to prime the market for launch within a year. The Ovulona is positioned as a life-long routinely used tool for health awareness, in a class of its own. Our technology represents a totally new diagnostic modality for reproductive medicine. It uses a sensor that records, will interpret (with instant display), and stores data charting reproductive cycles in terms of a previously unexplored biological process. Our core product will tell the user in plain language whether today is one of the 3 days that she can become pregnant, and it saves and makes the underlying folliculogenesis profile data available for use by physicians, and also by insurers and payers - a fundamental breakthrough. Target Markets: Virtually all women worldwide - from adolescence through menopause - seek solutions for one or more of the health issues that our sensor addresses

View a short narrated slide presentation. Login username: biozhena-associates Password: q410emt http://lifescienceintelligence.com/login.php

Click on thumbnails to enlarge

Contact vaclavkirsner@yahoo.com for more about bioZhena Corporation
by RaiseCapital.com | Posted on May 14, 2010

1 Comments